Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Structurally-modified antibody – immunoglobulin – or fragment...
Reexamination Certificate
2007-06-25
2011-11-15
Jiang, Dong (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Structurally-modified antibody, immunoglobulin, or fragment...
C530S388100, C530S391100, C530S351000
Reexamination Certificate
active
08057794
ABSTRACT:
The invention relates to antibody molecules having specificity for antigenic determinants of IL-17, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
REFERENCES:
patent: 2007/0009959 (2007-01-01), Lawson et al.
patent: 2008/0044423 (2008-02-01), Cochrane et al.
patent: 2008/0181888 (2008-07-01), Ambrose et al.
patent: WO 00/69463 (2000-11-01), None
patent: W02004106377 (2004-12-01), None
patent: WO 2004/106377 (2004-12-01), None
patent: WO 2005/001044 (2005-02-01), None
patent: W02005051422 (2005-06-01), None
patent: W02006013107 (2006-02-01), None
patent: WO 2006/013107 (2006-02-01), None
patent: W02006054059 (2006-05-01), None
patent: WO 2006/088833 (2006-08-01), None
patent: WO 2007/070750 (2007-06-01), None
patent: WO 2007/106769 (2007-09-01), None
patent: WO 2007/149032 (2007-12-01), None
patent: WO 2008/001063 (2008-01-01), None
patent: WO 2008/021156 (2008-02-01), None
patent: WO 2008/047134 (2008-04-01), None
Paul, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295, under the heading “Fv Structure and Diversity in Three Dimensions”.
Pascalis et al. Grafting of “abbreviated” complementarity-determining regions containing specificity-determining residues essential for ligand contact to engineer a less immunogenic humanized monoclonal antibody. J. Immunol. 2002, 169:3076-3084.
Dumont, F., IL-17 Cytokine/Receptor Families: Emerging Targets for the Modulation of Inflammatory Responses, Expert Opinion on Therapeutic Patents, Mar. 1, 2003, pp. 287-303, vol. 13, No. 3, Ashley Publications.
Chung Doo Ryeon et al., CD4+ T Cells Regulate Surgical and Postinfectious Adhesion Formation, The Journal of Experimental Medicine, Jun. 3, 2002, pp. 1471-1478, vol. 195, No. 11.
Hellings, Peter W. et al., Interleukin-17 Orchestrates the Granulocyte Influx into Airway after Allergen Inhalation in a Mouse Model of Allergic Asthma, American Journal of Respiratory Cell and Molecular Biology, Jan. 2003, pp. 42-50, vol. 28, No. 1, American Lung Association.
Numasaki, Muneo et al., Interleukin-17 Promotes Angiogenesis and Tumor Growth, Blood, Apr. 1, 2003, pp. 2620-2627, vol. 101, No. 7, W.B. Saunders Company.
Burchill, Matthew A., et al., Inhibition of Interleukin-17 Prevents the Development of Arthritis in Vaccinated Mice Challenged with Borrelia Burgdorferi, Infection and Immunity, Jun. 6, 2003, pp. 3437-3442, vol. 71, No. 6, American Society for Microbiology.
Boder, Eric T., et al., Directed Evolution of Antibody Fragments with Monovalent Femtomolar Antigen-Binding Affinity, Proceedings of the National Academy of Sciences of USA, Sep. 26, 2000, pp. 10701-10705, vol. 97, No. 20, National Academy of Science.
Thompson J., et al., Affinity Maturation of a High-Affinity Human Monoclonal Antibody Against the Third Hypervariable Loop of Human Immunodeficiency Virus: Use of Phage Display to Improve Affinity and Broaden Strain Reactivity, Journal of Molecular Biology, Feb. 16, 1996, pp. 77-88, vol. 256, No. 1.
International Search Report dated Sep. 26, 2007.
PCT International Search Report of PCT International Application PCT/GB2009/001026 filed Apr. 22, 2009.
PCT International Search Report of PCT International Application PCT/GB2007/003983 filed Oct. 18, 2007.
PCT International Search Report of PCT International Application PCT/GB2005/004392, dated Feb. 14, 2006.
Anti-human IL-17 Antibody, R& D Systems, Aug. 28, 2007, retrieved from internet: http://www.mdsystems, com/pdf/af317na.pdf on Mar. 27, 2008.
Chabaud, M. et al., “Contribution of Interleukin 17 to Synovium Matrix Destruction in Rheumatoid Arthritis”, Cytokine, Academic Press Ltd., vol. 12, No. 7, Jul. 2000, pp. 1092-1099.
Chung et al., “CD4+ T cells regulate surgical and postinfection adhesion formation”, The Journal Of Experimental Medicine, Jun. 3, 2002, vol. 195, No. 11, pp. 1471-1478.
Davies, Julian, Affinity Improvement of Single Antibody VH Domains: Residues in All Three Hypervariable Regions Affect Antigen Binding, Sep. 1996, pp. 169-179, vol. 2, No. 3.
Dumont, F. J., “IL-17 cytokine/receptor families: Emerging targets for the modulation of inflammatory responses”, Expert Opinion Of Therapeutic Patents, Ashley Publications, GB vol. 13, No. 3, Mar. 1, 2003, pp. 287-3030.
Hellings, et al., “Interleukin-17 orchestrates the granulocyte influx into airways after allergen inhalation in a mouse model of allergic asthma”, American Journal Of Respiratory Cell And Molecular biology, vol. 28, No. 1, Jan. 2003, pp. 42-50.
Holt, Lucy J.: Domain Antibodies: Proteins for Therapy, Trends in Biotechnology, Nov. 2003, pp. 484-490, vol. 21, No. 11.
Kotake et al., “IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis,” The Journal of Clincial Investigation, 103(9):1345-1352 (May 1999).
Numasaki, et al., “Interleukin-17 promotes angiogenesis and tumor growth”, Blood, vol. 101, No. 7, Apr. 1, 2003, pp. 2620-2627.
Paul, “Fv Structure and Diversity in Three Dimensions”, Fundamental Immunology, 3rd Edition, 1993, pp. 292-295.
Thompson, et al., “Affinity maturation of a high-affinity human monocional antibody against the third hypervariable loop of human immunodeficiency virus: use of phage display to improve affiinity and broaden strain reactivity”, Journal of Molecular Biology, vol. 256, No. 1, Feb. 16, 1996, pp. 77-88.
Vandamme et al.: Construction and characterization of a recombinant murine monocional antibody directed against human fibrin fragment-D dimer., J. Biochem. (1990) vol. 192, pp. 767-775.
Adams Ralph
Popplewell Andrew George
Rapecki Stephen Edward
Jiang Dong
McDonnell Boehnen & Hulbert & Berghoff LLP
UCB Pharma S.A.
LandOfFree
Antibody molecules which bind to human IL-17 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody molecules which bind to human IL-17, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody molecules which bind to human IL-17 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4307356